Phase 1-2 Study of Onapristone in Patients With Progesterone Receptor Expressing Cancers

Clinical trial NCT02052128 · UNKNOWN

Trial details

NCT number: NCT02052128
Sponsor: Arno Therapeutics
Status: UNKNOWN
Phase: Phase 1, Phase 2
Study type: INTERVENTIONAL

Progesterone Receptor Positive Tumor: Max 1 Line of Prior Chemotherapy, no Prior Hormone Therapy

Start date: 2014-01-01
Primary completion: 2015-10-01
Enrollment: 60

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.